Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment
Conditions
Atelectasis - Lung Cancer
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
prevention, radiofrequency treatment, lung cancer ablation
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Intervention
Name: RESMED AUTOSET S9
Type: Device
Overall Status
Recruiting
Summary
The project aims to study whether the application of a continuous positive airway pressure (CPAP) of 4 cm water vapor is a safe method in pulmonary radiofrequency intervention (PRF) lung cancer under conscious sedation compared with placebo. And, assess whether CPAP prevents atelectasis formation and consequently reduces the potential complications of PRF and improves procedural success
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- male and female aged 18 years and older

- Patient with a scheduled intervention for ablation of pulmonary malignant tumor with radiofrequency .

- Patient able to undergo tests and examinations required by the study.

Exclusion Criteria:

- Patients with CPAP intolerance test.

- Patients with progressive disease in which local treatment is not applicable

- Patients with intercurrent process (pleural effusion, pneumonia, ...).

- Patient unable to understand the proceedings.

- Pregnancy or breastfeeding.
Location
Hospital Clinic of Barcelona
Barcelona, Spain
Status: Recruiting
Contact: Sara Varea, BS (Biology) - +34932275400 - svarea@clinic.ub.es
Start Date
November 2014
Completion Date
December 2017
Sponsors
Sara Varea
Source
Fundacion Clinic per a la Recerca Biomédica
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page